Search Results - "Timsit, J.F."

Non-Homogeneous Cost-Effectiveness Modeling of a New CHG-Dressing for Preventing Catheter-Related Bloodstream Infections for Patients in Intensive Care Units by Maunoury, F, Motrunich, A, Ruckly, S, Timsit, J.F

Get full text

Pulmonary embolism detected by CT pulmonary angiography in hospitalized COVID-19 patients by Bunel, V., Saker, L., Ajzenberg, N., Timsit, J.F., Najem, S., Lortat-Jacob, B., Gay, J., Weisenburger, G., Mal, H., Khalil, A.

Get full text

CT characteristics of resolving ground-glass opacities in a lung cancer screening programme by Felix, L, Serra-Tosio, G, Lantuejoul, S, Timsit, J.F, Moro-Sibilot, D, Brambilla, C, Ferretti, G.R

“…Abstract Purpose This study aimed at evaluating the computed tomography (CT) characteristics of resolving localized ground-glass opacities (GGOs) in a…”
Get full text

Primary lung adenocarcinoma: characteristics by smoking habit and sex by NAGY-MIGNOTTE, H, GUILLEM, P, TIMSIT, J. F, MORO-SIBILOT, D, VESIN, A, TOFFART, A. C, COLONNA, M, BONNETERRE, V, BRICHON, P. Y, BRAMBILLA, C, BRAMBILLA, E, LANTUEJOUL, S

“…The incidence of adenocarcinoma is increasing, particularly among females. We sought to assess the role of tobacco consumption in clinical presentation…”
Get full text

Invasive aspergillosis: drug-dispensing systems as a source of filamentous fungal contamination in high-risk units? by Gibert, P, Brudieu, E, Timsit, J.F, Foroni, L, Thiébaut-Bertrand, A, Allenet, B, Pelloux, H, Brenier Pinchart, M.-P

“…Summary High-risk units with air-control measures at Grenoble University Hospital are equipped with automated dispensing systems that are filled daily using…”
Get full text

The quality of studies evaluating antimicrobial stewardship interventions: a systematic review by Schweitzer, V.A., van Heijl, I., van Werkhoven, C.H., Islam, J., Hendriks-Spoor, K.D., Bielicki, J., Bonten, M.J.M., Walker, A.S., Llewelyn, M.J., Harbarth, S., Huttner, B., Little, P., Rodriguez-Baño, J., Savoldi, A., van Smeden, M., Tacconelli, E., Timsit, J.F., Wolkewitz, M.

“…Antimicrobial stewardship aims to optimize antibiotic use and minimize selection of antimicrobial resistance. The methodological quality of published studies…”
Get full text

COVID19 au cours du Lupus Erythémateux systémique : résultats d’une analyse épidémiologique nationale by Mageau, A., Aldebert, G., Van Gysel, D., Papo, T., Timsit, J.F., Sacré, K.

Get full text

The impact of comorbidities and their stacking on short- and long-term prognosis of patients over 50 with community-acquired pneumonia by Blanc, E, Chaize, G, Fievez, S, Féger, C, Herquelot, E, Vainchtock, A, Timsit, J F, Gaillat, J

“…The prognosis of patients hospitalized with community-acquired pneumonia (CAP) with regards to intensive care unit (ICU) admission, short- and long-term…”
Get full text

PIN91 Ceftolozane-Tazobactam for the Treatment of Pneumonia Due to MULTI-Drug Resistant Ps eudomonas Aeruginosa - Results from a French Real-World Study by Levy-Bachelot, L., Castan, B., Akrich, B., Rzymska-Amode, A., Berthelot, A., Mootien, J., Ruimy, R., Ruiz, F., Timsit, J.F., Boutoille, D.

Get full text

Severe bradycardia in critically ill patients with COVID-19 – A cases report by Larue, J., Dejode, P., Timsit, J.F., Franchineau, G., Extramiana, F., Algalarrondo, V.

Get full text

Risque de poussée de lupus érythémateux systémique après un épisode sévère de COVID-19 : analyse de l’Entrepôt de Données de Santé de l’AP–HP by Mageau, A., Timsit, J.F., Papo, T., Sacre, K.

“…Les interférons de type 1 étant impliqués dans la physiopathologie du lupus érythémateux systémique (LES) et dans la réponse immunitaire anti-COVID-19, un…”
Get full text

Risque de poussée de lupus érythémateux systémique après hospitalisation pour COVID-19 : analyse de l’entrepôt de données de santé de l’AP–HP by Mageau, A., Gerardin, C., Sallah, K., Papo, T., Timsit, J.F., Sacre, K.

Get full text

PIN87 - Non-Homogeneous Cost-Effectiveness Modeling of a New CHG-Dressing for Preventing Catheter-Related Bloodstream Infections for Patients in Intensive Care Units by Maunoury, F., Motrunich, A., Ruckly, S., Timsit, J.F.

Get full text

COVID-19 sévère et maladies auto-immunes ou inflammatoires incidentes : une étude épidémiologique nationale à partir des données du PMSI en 2020 by Helary, A., Mageau, A., Ruckly, S., Strukov, A., Papo, T., Timsit, J.F., Sacre, K.

“…Début août 2022, l’Organisation mondiale de la santé (OMS) recense plus de 580 millions de cas mondiaux cumulés d’infections à SARS-CoV-2 (COVID-19). Plusieurs…”
Get full text

Delayed management of Staphyloccocus aureus infective endocarditis in a Middle East respiratory syndrome coronavirus possible case hospitalized in 2015 in Paris, France by Bleibtreu, A., Arias, P., Vallois, D., Debit, A., Lermuzeaux, M., Rioux, C., Cabras, O., Lucet, J.C., Choquet, C., Timsit, J.F., Yazdanpanah, Y., Lescure, F.X.

Get full text

Performance and impact of a rapid method combining mass spectrometry and direct antimicrobial susceptibility testing on treatment adequacy of patients with ventilator-associated pneumonia by Le Dorze, M., Gault, N., Foucrier, A., Ruppé, E., Mourvillier, B., Woerther, P.L., Birgand, G., Montravers, P., Dilly, M.P., Tubach, F., Andremont, A., Timsit, J.F., Wolff, M., Armand-Lefèvre, L.

“…Inappropriate antibiotic therapy in ventilator-associated pneumonia (VAP) is associated with increased mortality. Using broad-spectrum antibiotics for 48 h…”
Get full text

Overall Survival Analysis of Stage Iv Non Small Cell Lung Cancer with Synchronous Isolated Metastasis in a Large Retrospective Cohort of 4935 Patients with Lung Cancer by Toffart, A.C., Duruisseaux, M., Nagy-Mignotte, H., Sakhri, L., Brichon, P.Y., Villa, J., Hoffmann, D., Guillem, P., Timsit, J.F., Moro-Sibilot, D.

Get full text

1264POVERALL SURVIVAL ANALYSIS OF STAGE IV NON SMALL CELL LUNG CANCER WITH SYNCHRONOUS ISOLATED METASTASIS IN A LARGE RETROSPECTIVE COHORT OF 4935 PATIENTS WITH LUNG CANCER by Toffart, A.C., Duruisseaux, M., Nagy-Mignotte, H., Sakhri, L., Brichon, P.Y., Villa, J., Hoffmann, D., Guillem, P., Timsit, J.F., Moro-Sibilot, D.

“…Abstract Aim: Aim: Stage IV NSCLC is considered as an incurable disease with median survival of approximately 12 months. Palliative platinum based chemotherapy…”
Get full text

Épidémiologie de la pneumopathie interstitielle dans le lupus érythémateux systémique en France: une étude à l’échelle nationale sur 10 ans by Mageau, A., Borie, R., Crestani, B., Timsit, J.F., Papo, T., Sacré, K.

“…Outre la pleurésie, les manifestations pulmonaires spécifiques du lupus érythémateux systémique (LES) comprennent principalement la pneumonie aiguë,…”
Get full text

Survie hospitalière après un épisode de COVID-19 sévère chez les patients lupiques : une étude cas-contrôle à l’échelle nationale by Mageau, A., Papo, T., Ruckly, S., Van Gysel, D., Sacré, K., Timsit, J.F.

“…Depuis l’apparition du SARS-CoV2, le pronostic des formes sévères de COVID-19 chez les patients atteins de lupus érythémateux systémique (LES) reste débattu…”
Get full text